Ingredients

The main ingredient is sodium phosphatidylcholine

Character

This product is a colorless and clear liquid.

Indication

Used for consciousness disorders after acute traumatic brain injury and brain surgery.

Specifications

2ml: 0.25g; 4ml：0.5g; 4ml: 1g

Usage and dosage

Intravenous infusion: 0.25-0.5g each time, once a day, diluted with 5% or 10% glucose injection and slowly dripped. A course of treatment lasts for 5-10 days.

Intravenous injection: 0.1-0.2g each time.

Intramuscular injection: 0.1-0.3g per day, divided into 1-2 injections.

Adverse reactions

Whole body: occasional fever, fatigue, allergic reactions, and in severe cases, reports of anaphylactic shock.

Cardiovascular system: Occasional temporary decrease in blood pressure, bradycardia, and tachycardia.

Digestive system: occasional nausea, vomiting, loss of appetite, stomach pain, burning sensation, diarrhea, and abnormal liver function.

Respiratory system: There have been reports of allergic asthma, and in severe cases, breathing difficulties and laryngeal edema may occur.

Nervous system: occasional dizziness, tremors, headaches, insomnia, excitement, restlessness, and spasms.

Skin features: Occasional rash and transient diplopia.

Matters needing attention

1. Patients with a history of drug allergies should use with caution.

2. Use with caution in patients with severe acute traumatic brain injury accompanied by cerebral hemorrhage, cerebral edema, and increased intracranial pressure.

3. Patients with epilepsy and hypotension should use with caution.

During intravenous injection, the administration speed should be slowed down as much as possible.

5. Intramuscular injection is generally not used, and if used, the injection site should be changed frequently.

6. Please refer to the latest version of the "Clinical Medication Guidelines" during clinical use.

Drug overdose

Excessive dosage may cause symptoms such as nausea, vomiting, loss of appetite, headache, insomnia, excitement, spasms, etc. It can be reduced and treated accordingly.

Drug interactions

When used in patients with tremor paralysis, this product should not be combined with levodopa, otherwise it may cause muscle stiffness deterioration.